The serotonin theory of depression: a systematic umbrella review of the evidence
Joanna Moncrieff
1, 2
,
Ruth E Cooper
3
,
Tom Stockmann
4
,
Simone Amendola
5
,
Michael P. Hengartner
6
,
Mark A. Horowitz
1, 2
2
Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, UK
|
4
Psychiatry-UK, Cornwall, UK
|
Publication type: Journal Article
Publication date: 2022-07-20
scimago Q1
wos Q1
SJR: 4.022
CiteScore: 22.1
Impact factor: 10.1
ISSN: 13594184, 14765578
PubMed ID:
35854107
Molecular Biology
Cellular and Molecular Neuroscience
Psychiatry and Mental health
Abstract
The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or activity in a systematic umbrella review of the principal relevant areas of research. PubMed, EMBASE and PsycINFO were searched using terms appropriate to each area of research, from their inception until December 2020. Systematic reviews, meta-analyses and large data-set analyses in the following areas were identified: serotonin and serotonin metabolite, 5-HIAA, concentrations in body fluids; serotonin 5-HT1A receptor binding; serotonin transporter (SERT) levels measured by imaging or at post-mortem; tryptophan depletion studies; SERT gene associations and SERT gene-environment interactions. Studies of depression associated with physical conditions and specific subtypes of depression (e.g. bipolar depression) were excluded. Two independent reviewers extracted the data and assessed the quality of included studies using the AMSTAR-2, an adapted AMSTAR-2, or the STREGA for a large genetic study. The certainty of study results was assessed using a modified version of the GRADE. We did not synthesise results of individual meta-analyses because they included overlapping studies. The review was registered with PROSPERO (CRD42020207203). 17 studies were included: 12 systematic reviews and meta-analyses, 1 collaborative meta-analysis, 1 meta-analysis of large cohort studies, 1 systematic review and narrative synthesis, 1 genetic association study and 1 umbrella review. Quality of reviews was variable with some genetic studies of high quality. Two meta-analyses of overlapping studies examining the serotonin metabolite, 5-HIAA, showed no association with depression (largest n = 1002). One meta-analysis of cohort studies of plasma serotonin showed no relationship with depression, and evidence that lowered serotonin concentration was associated with antidepressant use (n = 1869). Two meta-analyses of overlapping studies examining the 5-HT1A receptor (largest n = 561), and three meta-analyses of overlapping studies examining SERT binding (largest n = 1845) showed weak and inconsistent evidence of reduced binding in some areas, which would be consistent with increased synaptic availability of serotonin in people with depression, if this was the original, causal abnormaly. However, effects of prior antidepressant use were not reliably excluded. One meta-analysis of tryptophan depletion studies found no effect in most healthy volunteers (n = 566), but weak evidence of an effect in those with a family history of depression (n = 75). Another systematic review (n = 342) and a sample of ten subsequent studies (n = 407) found no effect in volunteers. No systematic review of tryptophan depletion studies has been performed since 2007. The two largest and highest quality studies of the SERT gene, one genetic association study (n = 115,257) and one collaborative meta-analysis (n = 43,165), revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression. The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Molecular Psychiatry
29 publications, 4.76%
|
|
|
International Journal of Molecular Sciences
22 publications, 3.61%
|
|
|
Frontiers in Psychiatry
13 publications, 2.13%
|
|
|
Journal of Affective Disorders
13 publications, 2.13%
|
|
|
Scientific Reports
9 publications, 1.48%
|
|
|
Biomedicines
8 publications, 1.31%
|
|
|
Frontiers in Pharmacology
6 publications, 0.99%
|
|
|
Translational Psychiatry
6 publications, 0.99%
|
|
|
Pharmaceuticals
5 publications, 0.82%
|
|
|
Behavioural Brain Research
5 publications, 0.82%
|
|
|
Cureus
5 publications, 0.82%
|
|
|
Journal of Psychiatric Research
5 publications, 0.82%
|
|
|
BMJ
5 publications, 0.82%
|
|
|
Brain Sciences
4 publications, 0.66%
|
|
|
International Journal of Mental Health Nursing
4 publications, 0.66%
|
|
|
European Archives of Psychiatry and Clinical Neuroscience
4 publications, 0.66%
|
|
|
Frontiers in Neuroscience
4 publications, 0.66%
|
|
|
Brain, Behavior, and Immunity
4 publications, 0.66%
|
|
|
Psychiatry Research
4 publications, 0.66%
|
|
|
Progress in Neuro-Psychopharmacology and Biological Psychiatry
4 publications, 0.66%
|
|
|
Cells
4 publications, 0.66%
|
|
|
European Neuropsychopharmacology
4 publications, 0.66%
|
|
|
Neuropharmacology
4 publications, 0.66%
|
|
|
Frontiers in Psychology
4 publications, 0.66%
|
|
|
Molecular Neurobiology
4 publications, 0.66%
|
|
|
American Journal of Clinical Hypnosis
3 publications, 0.49%
|
|
|
Journal of Mental Health
3 publications, 0.49%
|
|
|
Biological Psychiatry
3 publications, 0.49%
|
|
|
Current Psychology
3 publications, 0.49%
|
|
|
5
10
15
20
25
30
|
Publishers
|
20
40
60
80
100
120
140
160
|
|
|
Springer Nature
144 publications, 23.65%
|
|
|
Elsevier
144 publications, 23.65%
|
|
|
MDPI
77 publications, 12.64%
|
|
|
Frontiers Media S.A.
40 publications, 6.57%
|
|
|
Wiley
31 publications, 5.09%
|
|
|
Taylor & Francis
28 publications, 4.6%
|
|
|
Cold Spring Harbor Laboratory
18 publications, 2.96%
|
|
|
SAGE
15 publications, 2.46%
|
|
|
BMJ
8 publications, 1.31%
|
|
|
Oxford University Press
8 publications, 1.31%
|
|
|
American Chemical Society (ACS)
6 publications, 0.99%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 0.99%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 0.82%
|
|
|
Cambridge University Press
5 publications, 0.82%
|
|
|
Research Square Platform LLC
5 publications, 0.82%
|
|
|
Public Library of Science (PLoS)
5 publications, 0.82%
|
|
|
F1000 Research
4 publications, 0.66%
|
|
|
Georg Thieme Verlag KG
3 publications, 0.49%
|
|
|
SciELO
3 publications, 0.49%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.49%
|
|
|
Korean College of Neuropsychopharmacology
3 publications, 0.49%
|
|
|
Mary Ann Liebert
2 publications, 0.33%
|
|
|
Portland Press
2 publications, 0.33%
|
|
|
S. Karger AG
2 publications, 0.33%
|
|
|
JMIR Publications
2 publications, 0.33%
|
|
|
Mark Allen Group
2 publications, 0.33%
|
|
|
Walter de Gruyter
2 publications, 0.33%
|
|
|
PeerJ
1 publication, 0.16%
|
|
|
Scientific Research Publishing
1 publication, 0.16%
|
|
|
20
40
60
80
100
120
140
160
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
609
Total citations:
609
Citations from 2024:
398
(65.35%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Moncrieff J. et al. The serotonin theory of depression: a systematic umbrella review of the evidence // Molecular Psychiatry. 2022. Vol. 28. No. 8.
GOST all authors (up to 50)
Copy
Moncrieff J., Cooper R. E., Stockmann T., Amendola S., Hengartner M. P., Horowitz M. A. The serotonin theory of depression: a systematic umbrella review of the evidence // Molecular Psychiatry. 2022. Vol. 28. No. 8.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/s41380-022-01661-0
UR - https://doi.org/10.1038/s41380-022-01661-0
TI - The serotonin theory of depression: a systematic umbrella review of the evidence
T2 - Molecular Psychiatry
AU - Moncrieff, Joanna
AU - Cooper, Ruth E
AU - Stockmann, Tom
AU - Amendola, Simone
AU - Hengartner, Michael P.
AU - Horowitz, Mark A.
PY - 2022
DA - 2022/07/20
PB - Springer Nature
IS - 8
VL - 28
PMID - 35854107
SN - 1359-4184
SN - 1476-5578
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Moncrieff,
author = {Joanna Moncrieff and Ruth E Cooper and Tom Stockmann and Simone Amendola and Michael P. Hengartner and Mark A. Horowitz},
title = {The serotonin theory of depression: a systematic umbrella review of the evidence},
journal = {Molecular Psychiatry},
year = {2022},
volume = {28},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1038/s41380-022-01661-0},
number = {8},
doi = {10.1038/s41380-022-01661-0}
}